Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:278065.
doi: 10.1155/2015/278065. Epub 2015 May 27.

Stiff Person Syndrome: A Rare Neurological Disorder, Heterogeneous in Clinical Presentation and Not Easy to Treat

Affiliations

Stiff Person Syndrome: A Rare Neurological Disorder, Heterogeneous in Clinical Presentation and Not Easy to Treat

Susanne Buechner et al. Case Rep Neurol Med. 2015.

Abstract

Background. Stiff person syndrome (SPS) is a rare neurological disorder characterized by progressive rigidity of axial and limb muscles associated with painful spasms. SPS can be classified into classic SPS, paraneoplastic SPS, and SPS variants. Its underlying pathogenesis is probably autoimmune, as in most cases antibodies against glutamic acid decarboxylase (GAD) are observed. Similarly, paraneoplastic SPS is usually linked to anti-amphiphysin antibodies. Treatment is based on drugs enhancing gamma-aminobutyric acid (GABA) transmission and immunomodulatory agents. Case Series. Patient 1 is a 45-year-old male affected by the classic SPS, Patient 2 is a 73-year-old male affected by paraneoplastic SPS, and Patient 3 is a 68-year-old male affected by the stiff limb syndrome, a SPS variant where symptoms are confined to the limbs. Symptoms, diagnostic findings, and clinical course were extremely variable in the three patients, and treatment was often unsatisfactory and not well tolerated, thus reducing patient compliance. Clinical manifestations also included some unusual features such as recurrent vomiting and progressive dysarthria. Conclusions. SPS is a rare disorder that causes significant disability. Because of its extensive clinical variability, a multitask and personalized treatment is indicated. A clearer understanding of uncommon clinical features and better-tolerated therapeutic strategies are still needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hypertrophy of masseter muscle. Facial stiffness makes eating difficult.

References

    1. Hadavi S., Noyce A. J., Leslie R. D., Giovannoni G. Stiff person syndrome. Practical Neurology. 2011;11(5):272–282. doi: 10.1136/practneurol-2011-000071. - DOI - PubMed
    1. Baizabal-Carvallo J. F., Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. Journal of Neurology, Neurosurgery & Psychiatry. 2014 doi: 10.1136/jnnp-2014-309201. - DOI - PubMed
    1. Ho C. S. H., Ho R. C. M., Wilder-Smith E. P. Stiff person syndrome masquerading as panic attacks. The Lancet. 2014;383(9917):p. 668. doi: 10.1016/s0140-6736(14)60127-6. - DOI - PubMed
    1. Dalakas M. C. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Current Treatment Options in Neurology. 2009;11(2):102–110. doi: 10.1007/s11940-009-0013-9. - DOI - PubMed
    1. Murinson B. B., Guarnaccia J. B. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology. 2008;71(24):1955–1958. doi: 10.1212/01.wnl.0000327342.58936.e0. - DOI - PMC - PubMed

LinkOut - more resources